Gradient Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Gradient Capital Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35M	Sell	5,325 -64	-1%	-$14.9K	0.31%	63
2026 Q1	$1.32M	Sell	5,389 -40	-0.7%	-$9.32K	0.34%	60
2025 Q4	$1.12M	Buy	5,429 +5	+0.1%	+$989	0.29%	65
2025 Q3	$1.01M	Buy	5,424 +50	+0.9%	+$8.57K	0.27%	66
2025 Q2	$821K	Sell	5,374 -242	-4%	-$37.2K	0.24%	74
2025 Q1	$931K	Sell	5,616 -197	-3%	-$30.8K	0.3%	63
2024 Q4	$841K	Sell	5,813 -578	-9%	-$89.6K	0.27%	66
2024 Q3	$1.04M	Buy	6,391 +42	+0.7%	+$6.69K	0.34%	60
2024 Q2	$928K	Sell	6,349 -1,086	-15%	-$162K	0.33%	61
2024 Q1	$1.18M	Sell	7,435 -536	-7%	-$85.3K	0.43%	52
2023 Q4	$1.25M	Sell	7,971 -788	-9%	-$121K	0.48%	48
2023 Q3	$1.36M	Buy	8,759 +27	+0.3%	+$4.46K	0.57%	40
2023 Q2	$1.45M	Buy	8,732 +460	+6%	+$74.2K	0.58%	39
2023 Q1	$1.28M	Sell	8,272 -394	-5%	-$63.6K	0.55%	41
2022 Q4	$1.53M	Buy	8,666 +545	+7%	+$94.1K	0.7%	35
2022 Q3	$1.33M	Buy	8,121 +79	+1%	+$13.4K	0.63%	37
2022 Q2	$1.43M	Buy	8,042 +203	+3%	+$36.2K	0.68%	39
2022 Q1	$1.39M	Buy	7,839 +10	+0.1%	+$1.7K	0.59%	43
2021 Q4	$1.34M	Buy	7,829 +349	+5%	+$57.1K	0.56%	43
2021 Q3	$1.21M	Buy	7,480 +414	+6%	+$70.6K	0.55%	41
2021 Q2	$1.16M	Buy	7,066 +582	+9%	+$96.4K	0.55%	41
2021 Q1	$1.07M	Sell	6,484 -827	-11%	-$134K	0.56%	38
2020 Q4	$1.15M	Buy	7,311 +1,580	+28%	+$233K	0.66%	36
2020 Q3	$853K	Buy	5,731 +199	+4%	+$29.4K	0.53%	44
2020 Q2	$778K	Sell	5,532 -315	-5%	-$45.9K	0.53%	44
2020 Q1	$767K	Buy	5,847 +57	+1%	+$8.09K	0.62%	40
2019 Q4	$845K	Sell	5,790 -484	-8%	-$65.6K	0.59%	39
2019 Q3	$812K	Sell	6,274 -862	-12%	-$114K	0.61%	44
2019 Q2	$994K	Sell	7,136 -164	-2%	-$22.7K	0.76%	33
2019 Q1	$1.02M	Buy	7,300 +3	+0%	+$402	0.81%	32
2018 Q4	$942K	Buy	7,297 +3	+0%	+$418	0.81%	30
2018 Q3	$1.01M	Buy	7,294 +2	+0%	+$266	0.85%	27
2018 Q2	$885K	Buy	7,292 +305	+4%	+$38.1K	0.82%	30
2018 Q1	$895K	Buy	6,987 +1,273	+22%	+$172K	0.89%	26
2017 Q4	$798K	Buy	+5,714	New	+$796K	0.82%	27

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Gradient Capital Advisors's JNJ Position: Q2 2026 in Review

Gradient Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q2 2026, selling an estimated $14.9K and leaving 5,325 shares worth $1.35M. The position accounts for 0.31% of the portfolio, ranked #63.

Gradient Capital Advisors first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.53M in Q4 2022. 1,021 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Gradient Capital Advisors held 5,325 shares of Johnson & Johnson worth $1.35M as of Q2 2026.
Gradient Capital Advisors sold 64 Johnson & Johnson shares in Q2 2026, an estimated $14.9K.
Johnson & Johnson made up 0.31% of Gradient Capital Advisors's portfolio in Q2 2026, its #63 holding.
Gradient Capital Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
Gradient Capital Advisors's Johnson & Johnson position peaked at $1.53M in Q4 2022.
1,021 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Gradient Capital Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.